The effects of low-molecular-weight heparin on lung and pulmonary artery injuries in acute pulmonary embolism rat model via platelet-derived growth factor-β
Objective: To evaluate the effects of anticoagulant agent (low-molecular-weight heparin, LMWH) on the pulmonary artery intima hyperplasia of rats with acute pulmonary embolism (APE) by assaying platelet-derived growth factor-β (PDGF-β). Methods: A total of 90 Sprague-Dawley rats were randomly assign...
Main Authors: | Bing Zhou, Gaozhong Sun, Fuyang Mei, Heyun Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-05-01
|
Series: | Saudi Pharmaceutical Journal |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1319016417300889 |
Similar Items
-
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
by: Baumgarten, P., et al.
Published: (2022) -
Massive Fatal Pulmonary Embolism While on Therapeutic Heparin Drip
by: Said Hajouli MD
Published: (2020-03-01) -
Assessment of the effects of low molecular heparins in pulmonary embolism prophylaxis
by: Michał Piwoński, et al.
Published: (2019-05-01) -
Role of heparin in pulmonary cell populations in an in-vitro model of acute lung injury
by: Marta Camprubí–Rimblas, et al.
Published: (2017-05-01) -
Intimal sarcoma of the pulmonary artery presenting as pulmonary embolism
by: Plata, María Camila, et al.
Published: (2017-07-01)